JPRN-UMIN000013380招募中3 期
A non-randomized confirmatory study to expand the indication of fertility-sparing surgery for patients with epithelial ovarian cancer (JCOG1203, FSS for EOC) - A non-randomized confirmatory study to expand the indication of fertility-sparing surgery for patients with epithelial ovarian cancer (JCOG1203, FSS for EOC)
Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 600 人开始时间: 2014年3月10日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 42years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •(1)Synchronous or metachronous (within 5 years) malignancies except for carcinoma in situ or intramucosal tumors curatively treated with local therapy (2) Active systemic infections to be treated. (3) Body temperature of 38 or more degrees Celsius (4) Women during pregnancy, possible pregnancy, or breast-feeding (5) Psychiatric disease (6) Continuous systemic steroid treatment (7) Uncontrolled diabetes mellitus or routine administration of insulin (8) Uncontrolled hypertension (9) Unstable angina or prior myocardial infarction with in 6 months (10) HBs antigen positive, HCV antibody positive, HIV antibody positive (11) Interstitial pneumonia, pulmonary fibrosis, severe pulmonary emphysema (12) hypersensitivity to polyoxyethylated castor oil (13) hypersensitivity to alcohol
研究者
相似试验
已完成
3 期
A non-randomized confirmatory study of definitive chemoradiotherapy including salvage treatment in patients with clinical stage II/III esophageal carcinoma (JCOG 0909,EC-CRT+Salvage-sP3)esophageal neoplasmJPRN-UMIN000003534Japan Clinical Oncology Group(JCOG)95
尚未招募
Unknown
se of night-time postural care with online caregiver support for children with severe cerebral palsy and its effect of preventing postural deformitiesCerebral palsy Children with profound intellectual and multiple disabilitiesJPRN-UMIN000050459Kansai Medical University20
尚未招募
3 期
An open-label, non-randomized extension study to evaluate the long-term efficacy, safety and tolerability of iptacopan (LNP023) in subjects with C3 glomerulopathy or idiopathic immune-complex-membranoproliferative glomerulonephritisNL-OMON56390ovartis5
进行中（未招募）
1 期
ong-term efficacy, safety and tolerability of LNP023 in C3GEUCTR2018-004253-24-GBovartis Pharma AG27
进行中（未招募）
1 期
Study to assess long-term safety and efficacy of CDZ173 in patients with APDS/PASLIAPDS/PASLI (Activated phosphoinositide 3-kinase delta syndrome/p110d-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency)MedDRA version: 20.0Level: PTClassification code 10064859Term: Primary immunodeficiency syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-000468-41-NLPharming Technologies B.V.42